No products in the cart.
Bdparib 300 mg (Rucaparib)
Bdparib 300 mg is an oral Rucaparib tablet used for BRCA-mutated ovarian cancer, ideal for maintenance therapy or recurrent disease treatment.
Bdparib 300 mg (Rucaparib)
| Active Ingredient | Rucaparib |
|---|---|
| Indication: | Treatment of Prostate and Ovarian Cancers |
| Manufacturer: | BDR Pharmaceuticals |
| Packaging | 60 Tablets in bottle |
| Strength | 300mg |
Bdparib 300 mg contains Rucaparib, a potent PARP inhibitor (Poly ADP-Ribose Polymerase inhibitor) used in the treatment of advanced ovarian, fallopian tube, and peritoneal cancers, particularly in patients with BRCA1/BRCA2 gene mutations. It is often used as maintenance therapy following a favorable response to platinum-based chemotherapy or as monotherapy in certain relapsed cancers.
Rucaparib works by preventing cancer cells from repairing their damaged DNA, leading to cell death—especially in tumors already deficient in DNA repair mechanisms due to BRCA mutations. Bdparib 300 mg is taken orally, typically twice daily, and is approved for long-term use under strict medical supervision.
| pack size | 60 Tablets – USD $11.00Per pill, 120 Tablets – USD $10.67 Per pill, 180 Tablets – USD $10.44 Per pill |
|---|
Be the first to review “Bdparib 300 mg (Rucaparib)”
You must be logged in to post a review.
Related Products
Buy Imat 400 Mg (Imatinib)
Price range: $130.00 through $375.00
Buy Anabrez 1Mg (Anastrozole)
Price range: $50.00 through $145.00
Buy Imatib 400 Mg (Imatinib)
Price range: $355.00 through $1,050.00
Buy Aromasin 25 Mg (Exemestane)
Price range: $95.00 through $323.00
There are no reviews yet.